Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.

D W Hommes; T L Mikhajlova; S Stoinov; D Stimac; B Vucelic; J Lonovics; M Zákuciová; G D'Haens; G Van Assche; S Ba

doi:10.1136/gut.2005.079392

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.

Identifier:nobleid.org/w1/20260515/F6D4FAC9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F6D4FAC9.svg?ark=w1%2F20260515%2FF6D4FAC9)](https://nobleid.org/work/w1/20260515/F6D4FAC9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease.

Identifier:nobleid.org/w1/20260515/F6D4FAC9

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F6D4FAC9.svg?ark=w1%2F20260515%2FF6D4FAC9)](https://nobleid.org/work/w1/20260515/F6D4FAC9)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work